Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Excerpta Medica BV - Adelphi GroupExcerpta Medica BV - Adelphi Group
VS
Alembic Pharmaceuticals LimitedAlembic Pharmaceuticals Limited
Excerpta Medica BV - Adelphi Group

Excerpta Medica BV - Adelphi Group

Professor W.H. Keesomlaan 4, Amstelveen, 1183 DJ, NL

Last Update: 02/04/2026

View Profile
753/1000Fair

Excerpta Medica is a full-service, global medical communications agency with decades of experience partnering with the healthcare industry. With offices in Amsterdam, London, and Philadelphia, and an extensive network through Omnicom and Adelphi, we can develop innovati...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:196
Subsidiaries:32
12-month incidents
0
Known data breaches
0
Attack type number
0
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Alembic Road, Vadodara, 390003, IN

Last Update: 20/09/2026

View Profile
Between 750 and 799
http://www.alembic-india.com
759/1000Fair

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is t...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,168
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Excerpta Medica BV - Adelphi Group

Excerpta Medica BV - Adelphi Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Excerpta Medica BV - Adelphi Group in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2026.

Incidents

Incident History - Excerpta Medica BV - Adelphi Group (X = Date, Y = Severity)

Excerpta Medica BV - Adelphi Group cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Alembic Pharmaceuticals Limited (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Excerpta Medica BV - Adelphi Group

Excerpta Medica BV - Adelphi Group

Incidents
No explicit notable incidents reported.
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has the best AI Cybersecurity Score ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has experienced more cyber incidents in the past ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has experienced more cyber incidents this year ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has experienced at least one ransomware attack ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has experienced at least one data breach ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has experienced at least one targeted cyberattack ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has experienced at least one vulnerability ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one holds the most compliance certifications ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one holds the fewest compliance certifications ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has the most subsidiaries ?
Between Excerpta Medica BV - Adelphi Group company and Alembic Pharmaceuticals Limited company, which one has the largest number of employees ?
Between Excerpta Medica BV - Adelphi Group and Alembic Pharmaceuticals Limited, which company holds both SOC 2 Type 1 certifications ?
Between Excerpta Medica BV - Adelphi Group and Alembic Pharmaceuticals Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Excerpta Medica BV - Adelphi Group or Alembic Pharmaceuticals Limited ?
Which company is PCI DSS compliant - Excerpta Medica BV - Adelphi Group or Alembic Pharmaceuticals Limited ?
Between Excerpta Medica BV - Adelphi Group and Alembic Pharmaceuticals Limited, which company complies with HIPAA regulations for healthcare data ?
Between Excerpta Medica BV - Adelphi Group and Alembic Pharmaceuticals Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-84411
SUMMARY

The web management service in affected RouterOS versions contains an integer underflow in its HTTP request body handling that is reachable before authentication. This can be leveraged by an unauthenticated network attacker to achieve arbitrary code execution as root, or to cause a denial of service, using a single crafted request.

PUBLISHED
Date2026-10-02
UPDATED
Date2026-10-02
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-105051
SUMMARY

Denuvo Anti-Tamper through 2026-03-04 allows bypass of a hypervisor presence check via CPUID interception (SimpleSvm.sys on AMD; hyperkd.sys and hyperhv.dll on Intel).

PUBLISHED
Date2026-10-02
UPDATED
Date2026-10-02
RISK INFORMATION (Score: 1.9)
CVSS3
Base Score: 1.9
Complexity: HIGH
CVSS:3.1/AV:L/AC:H/PR:H/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
0.5
CVE-2026-105050
SUMMARY

PeaZip before 11.3.0, in a non-default configuration, is vulnerable to OS command injection via a filename in an archive because "quotation character already used in the string" is mishandled.

PUBLISHED
Date2026-10-02
UPDATED
Date2026-10-02
RISK INFORMATION (Score: )
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:P/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-105049
SUMMARY

Zilliz Attu before 3.0.0 has a Playground feature that does not require authentication for proxying arbitrary HTTP and HTTPS requests to URLs on the public internet.

PUBLISHED
Date2026-10-02
UPDATED
Date2026-10-02
RISK INFORMATION (Score: 5.8)
CVSS3
Base Score: 5.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-105048
SUMMARY

The Playground feature of Zilliz Attu before 3.0.0 allows SSRF (proxying of requests to private IP addresses).

PUBLISHED
Date2026-10-02
UPDATED
Date2026-10-02
RISK INFORMATION (Score: 4)
CVSS3
Base Score: 4.0
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2